REVOLUTION in Heart Failure Care and SELECT Highlights From the European Society of Cardiology-Heart Failure Association Heart Failure & World Congress on Acute Heart Failure 2024.
作者信息
Reza Nosheen, Pellicori Pierpaolo, Starling Randall C
机构信息
Division of Cardiovascular Medicine, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK.
出版信息
J Card Fail. 2024 Sep;30(9):1157-1160. doi: 10.1016/j.cardfail.2024.05.004. Epub 2024 Jun 3.
Abstract
摘要
相似文献
1
REVOLUTION in Heart Failure Care and SELECT Highlights From the European Society of Cardiology-Heart Failure Association Heart Failure & World Congress on Acute Heart Failure 2024.心力衰竭护理的变革与2024年欧洲心脏病学会-心力衰竭协会心力衰竭及急性心力衰竭世界大会精选亮点
J Card Fail. 2024 Sep;30(9):1157-1160. doi: 10.1016/j.cardfail.2024.05.004. Epub 2024 Jun 3.
2
A spotlight on congestion in acute heart failure: a joint session with the Romanian Society of Cardiology (part I).聚焦急性心力衰竭中的充血：与罗马尼亚心脏病学会的联合会议（第一部分）
Heart Fail Rev. 2025 Apr 29. doi: 10.1007/s10741-025-10515-0.
3
Highlights of the 2011 scientific sessions of the Congress of the Heart Failure Association of the European Society of Cardiology.2011年欧洲心脏病学会心力衰竭协会大会科学会议亮点
Future Cardiol. 2011 Nov;7(6):739-43. doi: 10.2217/fca.11.68.
4
The Heart Failure Association Congress confirms itself as the largest European Society of Cardiology sub-speciality congress.心力衰竭协会大会已确认为欧洲心脏病学会最大的亚专业大会。
Eur Heart J Cardiovasc Pharmacother. 2017 Jan;3(1):5-6. doi: 10.1093/ehjcvp/pvw017.
5
Quality of life in heart failure. The heart of the matter. A scientific statement of the Heart Failure Association and the European Association of Preventive Cardiology of the European Society of Cardiology.心力衰竭患者的生活质量。问题的核心。欧洲心脏病学会心力衰竭协会和欧洲预防心脏病学协会的科学声明。
Eur J Heart Fail. 2025 Jul;27(7):1159-1173. doi: 10.1002/ejhf.3440. Epub 2025 Mar 12.
6
Knowledge and application of ESC/HFA guidelines in the management of advanced heart failure.欧洲心脏病学会/心力衰竭协会（ESC/HFA）指南在晚期心力衰竭管理中的知识与应用
Eur J Heart Fail. 2025 Jun;27(6):1126-1135. doi: 10.1002/ejhf.3530. Epub 2024 Nov 19.
7
Pathophysiology and clinical use of agents with vasodilator properties in acute heart failure. A scientific statement of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).血管扩张剂在急性心力衰竭中的病理生理学及临床应用。欧洲心脏病学会（ESC）心力衰竭协会（HFA）的科学声明。
Eur J Heart Fail. 2025 Jun;27(6):1067-1088. doi: 10.1002/ejhf.3673. Epub 2025 May 4.
8
The European Society of Cardiology Heart Failure Association Annual Congress.欧洲心脏病学会心力衰竭协会年度大会
Eur J Heart Fail. 2016 May;18(5):454-5. doi: 10.1002/ejhf.4_536.
9
Meeting highlights from the 2013 European Society of Cardiology Heart Failure Association Winter Meeting on Translational Heart Failure Research.2013年欧洲心脏病学会心力衰竭协会关于转化性心力衰竭研究的冬季会议亮点。
Eur J Heart Fail. 2014 Jan;16(1):6-14. doi: 10.1002/ejhf.10. Epub 2013 Dec 14.
10
New trial evidence and guidelines on heart failure: news from the European Society of Cardiology Congress 2021.心力衰竭的新试验证据与指南：来自2021年欧洲心脏病学会大会的消息
Eur Heart J Cardiovasc Pharmacother. 2021 Nov 3;7(6):e89-e90. doi: 10.1093/ehjcvp/pvab071.
引用本文的文献
1
Emerging Role of Natriuretic Peptides in Diabetes Care: A Brief Review of Pertinent Recent Literature.利钠肽在糖尿病护理中的新兴作用：近期相关文献综述
Diagnostics (Basel). 2024 Oct 9;14(19):2251. doi: 10.3390/diagnostics14192251.
本文引用的文献
1
Diuresis Efficacy in Ambulatory Congested Heart Failure Patients: Intrapatient Comparison of 3 Diuretic Regimens (DEA-HF).门诊充血性心力衰竭患者的利尿疗效：三种利尿方案的患者内比较（DEA-HF）
JACC Heart Fail. 2024 Aug;12(8):1396-1405. doi: 10.1016/j.jchf.2024.04.014. Epub 2024 May 11.
2
Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy.肥厚型梗阻性心肌病的治疗药物：Aficamten
N Engl J Med. 2024 May 30;390(20):1849-1861. doi: 10.1056/NEJMoa2401424. Epub 2024 May 13.
3
Redefining Iron Deficiency in Patients With Chronic Heart Failure.重新定义慢性心力衰竭患者的缺铁症。
Circulation. 2024 Jul 9;150(2):151-161. doi: 10.1161/CIRCULATIONAHA.124.068883. Epub 2024 May 11.
4
Pulmonary artery pressure monitoring in chronic heart failure: effects across clinically relevant subgroups in the MONITOR-HF trial.慢性心力衰竭肺动脉压监测：MONITOR-HF 试验中临床相关亚组的影响。
Eur Heart J. 2024 Aug 21;45(32):2954-2964. doi: 10.1093/eurheartj/ehae323.
5
Intravenous iron for heart failure, iron deficiency definitions, and clinical response: the IRONMAN trial.静脉铁剂治疗心力衰竭、铁缺乏定义和临床反应：IRONMAN 试验。
Eur Heart J. 2024 Apr 21;45(16):1410-1426. doi: 10.1093/eurheartj/ehae086.
6
Design and baseline characteristics of SALT-HF trial: hypertonic saline therapy in ambulatory heart failure.SALT-HF 试验的设计和基线特征：门诊心力衰竭中高渗盐水治疗。
ESC Heart Fail. 2024 Jun;11(3):1767-1776. doi: 10.1002/ehf2.14720. Epub 2024 Feb 21.
7
Iron Deficiency in Heart Failure: A Scientific Statement from the Heart Failure Society of America.心力衰竭中的缺铁：美国心力衰竭学会科学声明。
J Card Fail. 2023 Jul;29(7):1059-1077. doi: 10.1016/j.cardfail.2023.03.025. Epub 2023 May 1.
8
Criteria for Iron Deficiency in Patients With Heart Failure.心力衰竭患者铁缺乏的标准。
J Am Coll Cardiol. 2022 Feb 1;79(4):341-351. doi: 10.1016/j.jacc.2021.11.039.
9
The struggle towards a Universal Definition of Heart Failure-how to proceed?迈向心力衰竭通用定义的努力——如何推进？
Eur Heart J. 2021 Jun 21;42(24):2331-2343. doi: 10.1093/eurheartj/ehab082.
10
Effect of liraglutide, a glucagon-like peptide-1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE)-a multicentre, double-blind, randomised, placebo-controlled trial.利拉鲁肽，一种胰高血糖素样肽-1 类似物，对伴有或不伴有糖尿病的稳定慢性心力衰竭患者左心室功能的影响（LIVE）-一项多中心、双盲、随机、安慰剂对照试验。
Eur J Heart Fail. 2017 Jan;19(1):69-77. doi: 10.1002/ejhf.657. Epub 2016 Oct 28.
Zotero 插件